메뉴 건너뛰기




Volumn 5, Issue 1, 2016, Pages 86-95

Editor’s choice-recent therapeutic trials on fluid removal and vasodilation in acute heart failure

Author keywords

Acute heart failure; Fluid removal; Future directions; Vasodilating agents

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN NATRIURETIC PEPTIDE; CONIVAPTAN; CYCLIC AMP; DOPAMINE; ENDOTHELIN B RECEPTOR; FUROSEMIDE; METOLAZONE; MORPHINE; NESIRITIDE; NITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; ROLOFYLLINE; SERELAXIN; TEZOSENTAN; THIAZIDE DIURETIC AGENT; TOLVAPTAN; URODILATIN; VASOPRESSIN V2 RECEPTOR; DIURETIC AGENT; RECOMBINANT PROTEIN; RELAXIN; SERELAXIN PROTEIN, HUMAN;

EID: 84993804179     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872614560504     Document Type: Review
Times cited : (8)

References (65)
  • 2
    • 78149320923 scopus 로고    scopus 로고
    • 2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy
    • Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur Heart J 2010; 31: 2677-2687.
    • (2010) Eur Heart J , vol.31 , pp. 2677-2687
    • Dickstein, K.1    Vardas, P.E.2    Auricchio, A.3
  • 3
    • 36849084209 scopus 로고    scopus 로고
    • The pathophysiology of acute heart failure-is it all about fluid accumulation?
    • Cotter G, Felker GM, Adams KF, et al. The pathophysiology of acute heart failure-is it all about fluid accumulation? Am Heart J 2008; 155: 9-18.
    • (2008) Am Heart J , vol.155 , pp. 9-18
    • Cotter, G.1    Felker, G.M.2    Adams, K.F.3
  • 4
    • 33644878033 scopus 로고    scopus 로고
    • Acute heart failure syndromes: Current state and framework for future research
    • Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation 2005; 112: 3958-3968.
    • (2005) Circulation , vol.112 , pp. 3958-3968
    • Gheorghiade, M.1    Zannad, F.2    Sopko, G.3
  • 5
    • 41149164312 scopus 로고    scopus 로고
    • Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity-matched study
    • Ahmed A, Allman RM, Fonarow GC, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity-matched study. J Card Fail 2008; 14: 211-218.
    • (2008) J Card Fail , vol.14 , pp. 211-218
    • Ahmed, A.1    Allman, R.M.2    Fonarow, G.C.3
  • 6
    • 43249087615 scopus 로고    scopus 로고
    • Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF
    • Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF. Arch Intern Med 2008; 168: 847-854.
    • (2008) Arch Intern Med , vol.168 , pp. 847-854
    • Fonarow, G.C.1    Abraham, W.T.2    Albert, N.M.3
  • 7
    • 80054947580 scopus 로고    scopus 로고
    • Sympathetically mediated changes in capacitance: Redistribution of the venous reservoir as a cause of decompensation
    • Fallick C, Sobotka PA and Dunlap ME. Sympathetically mediated changes in capacitance: Redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 2011; 4: 669-675.
    • (2011) Circ Heart Fail , vol.4 , pp. 669-675
    • Fallick, C.1    Sobotka, P.A.2    Dunlap, M.E.3
  • 8
    • 0032080919 scopus 로고    scopus 로고
    • Systemic inflammation in patients with heart failure
    • Hasper D, Hummel M, Kleber FX, et al. Systemic inflammation in patients with heart failure. Eur Heart J 1998; 19: 761-765.
    • (1998) Eur Heart J , vol.19 , pp. 761-765
    • Hasper, D.1    Hummel, M.2    Kleber, F.X.3
  • 9
    • 0017332333 scopus 로고
    • Correlative classification of clinical and hemodynamic function after acute myocardial infarction
    • Forrester JS, Diamond GA and Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977; 39: 137-145.
    • (1977) Am J Cardiol , vol.39 , pp. 137-145
    • Forrester, J.S.1    Diamond, G.A.2    Swan, H.J.3
  • 10
    • 20044379730 scopus 로고    scopus 로고
    • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
    • Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
    • (2005) Eur Heart J , vol.26 , pp. 384-416
    • Nieminen, M.S.1    Bohm, M.2    Cowie, M.R.3
  • 11
    • 26044460566 scopus 로고    scopus 로고
    • Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial
    • Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 2005; 294: 1625-1633.
    • (2005) JAMA , vol.294 , pp. 1625-1633
    • Binanay, C.1    Califf, R.M.2    Hasselblad, V.3
  • 13
    • 33750731595 scopus 로고    scopus 로고
    • Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
    • Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217-2226.
    • (2006) JAMA , vol.296 , pp. 2217-2226
    • Gheorghiade, M.1    Abraham, W.T.2    Albert, N.M.3
  • 14
    • 84871058843 scopus 로고    scopus 로고
    • Ultrafiltration in decompensated heart failure with cardiorenal syndrome
    • Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304.
    • (2012) N Engl J Med , vol.367 , pp. 2296-2304
    • Bart, B.A.1    Goldsmith, S.R.2    Lee, K.L.3
  • 15
    • 77957730950 scopus 로고    scopus 로고
    • Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
    • Massie BM, O'Connor CM, Metra M, et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010; 363: 1419-1428.
    • (2010) N Engl J Med , vol.363 , pp. 1419-1428
    • Massie, B.M.1    O'Connor, C.M.2    Metra, M.3
  • 16
    • 33947713810 scopus 로고    scopus 로고
    • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
    • Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 2007; 297: 1319-1331.
    • (2007) JAMA , vol.297 , pp. 1319-1331
    • Konstam, M.A.1    Gheorghiade, M.2    Burnett, J.C.3
  • 17
    • 79960090547 scopus 로고    scopus 로고
    • Effect of nesiritide in patients with acute decompensated heart failure
    • O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
    • (2011) N Engl J Med , vol.365 , pp. 32-43
    • O'Connor, C.M.1    Starling, R.C.2    Hernandez, A.F.3
  • 18
    • 38949162580 scopus 로고    scopus 로고
    • Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation
    • Cotter G, Metra M, Milo-Cotter O, et al. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008; 10: 165-169.
    • (2008) Eur J Heart Fail , vol.10 , pp. 165-169
    • Cotter, G.1    Metra, M.2    Milo-Cotter, O.3
  • 19
    • 0024853289 scopus 로고
    • Neuroendocrine response in acute heart failure and the influence of treatment
    • Broqvist M, Dahlstrom U, Karlberg BE, et al. Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J 1989; 10: 1075-1083.
    • (1989) Eur Heart J , vol.10 , pp. 1075-1083
    • Broqvist, M.1    Dahlstrom, U.2    Karlberg, B.E.3
  • 20
    • 0141576813 scopus 로고    scopus 로고
    • Alveolar-capillary membrane dysfunction in heart failure: Evidence of a pathophysiologic role
    • Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: Evidence of a pathophysiologic role. Chest 2003; 124: 1090-1102.
    • (2003) Chest , vol.124 , pp. 1090-1102
    • Guazzi, M.1
  • 21
    • 0042354582 scopus 로고    scopus 로고
    • Hypoalbuminemia in elderly patients with acute diastolic heart failure
    • Arques S, Ambrosi P, Gelisse R, et al. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003; 42: 712-716.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 712-716
    • Arques, S.1    Ambrosi, P.2    Gelisse, R.3
  • 22
    • 40849111905 scopus 로고    scopus 로고
    • Cardiorenal interactions: Insights from the ESCAPE trial
    • Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: Insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51: 1268-1274.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1268-1274
    • Nohria, A.1    Hasselblad, V.2    Stebbins, A.3
  • 23
    • 10744231948 scopus 로고    scopus 로고
    • Relationship between heart failure treatment and development of worsening renal function among hospitalized patients
    • Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-338.
    • (2004) Am Heart J , vol.147 , pp. 331-338
    • Butler, J.1    Forman, D.E.2    Abraham, W.T.3
  • 24
    • 38949205222 scopus 로고    scopus 로고
    • Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance
    • Metra M, Nodari S, Parrinello G, et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. Eur J Heart Fail 2008; 10: 188-195.
    • (2008) Eur J Heart Fail , vol.10 , pp. 188-195
    • Metra, M.1    Nodari, S.2    Parrinello, G.3
  • 25
    • 84903794699 scopus 로고    scopus 로고
    • Renal dysfunction in acute congestive heart failure: A common problem for cardiologists and nephrologists
    • Graziani G, Pini D, Oldani S, et al. Renal dysfunction in acute congestive heart failure: A common problem for cardiologists and nephrologists. Heart Fail Rev 2014: 19: 699-708.
    • (2014) Heart Fail Rev , vol.19 , pp. 699-708
    • Graziani, G.1    Pini, D.2    Oldani, S.3
  • 26
    • 84883657695 scopus 로고    scopus 로고
    • The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction
    • Van Diepen S, Vavalle JP, Newby LK, et al. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med 2013; 41: 2080-2087.
    • (2013) Crit Care Med , vol.41 , pp. 2080-2087
    • Van Diepen, S.1    Vavalle, J.P.2    Newby, L.K.3
  • 27
    • 34848904566 scopus 로고    scopus 로고
    • Patterns of weight change preceding hospitalization for heart failure
    • Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007; 116: 1549-1554.
    • (2007) Circulation , vol.116 , pp. 1549-1554
    • Chaudhry, S.I.1    Wang, Y.2    Concato, J.3
  • 28
    • 85047932251 scopus 로고    scopus 로고
    • Continuous infusion versus bolus injection of loop diuretics in congestive heart failure
    • Salvador DR, Rey NR, Ramos GC, et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005: CD003178.
    • (2005) Cochrane Database Syst Rev
    • Salvador, D.R.1    Rey, N.R.2    Ramos, G.C.3
  • 29
    • 79952260198 scopus 로고    scopus 로고
    • Diuretic strategies in patients with acute decompensated heart failure
    • Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797-805.
    • (2011) N Engl J Med , vol.364 , pp. 797-805
    • Felker, G.M.1    Lee, K.L.2    Bull, D.A.3
  • 30
    • 78649448385 scopus 로고    scopus 로고
    • Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
    • Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010; 16: 922-930.
    • (2010) J Card Fail , vol.16 , pp. 922-930
    • Giamouzis, G.1    Butler, J.2    Starling, R.C.3
  • 31
    • 78049332540 scopus 로고    scopus 로고
    • Combination of loop diuretics with thiazide-type diuretics in heart failure
    • Jentzer JC, DeWald TA and Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010; 56: 1527-1534.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 1527-1534
    • Jentzer, J.C.1    DeWald, T.A.2    Hernandez, A.F.3
  • 32
    • 84890931629 scopus 로고    scopus 로고
    • Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure
    • Eng M and Bansal S. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure. Int J Cardiol 2014; 170: e68-e69.
    • (2014) Int J Cardiol , vol.170 , pp. e68-e69
    • Eng, M.1    Bansal, S.2
  • 33
    • 28244434083 scopus 로고    scopus 로고
    • Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial
    • Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005; 46: 2043-2046.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 2043-2046
    • Bart, B.A.1    Boyle, A.2    Bank, A.J.3
  • 34
    • 33846811342 scopus 로고    scopus 로고
    • Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure
    • Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 675-683
    • Costanzo, M.R.1    Guglin, M.E.2    Saltzberg, M.T.3
  • 36
    • 84885845957 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    • Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240-327.
    • (2013) Circulation , vol.128 , pp. e240-e327
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3
  • 37
    • 84894057345 scopus 로고    scopus 로고
    • Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial
    • Triposkiadis FK, Butler J, Karayannis G, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol 2014; 172: 115-121.
    • (2014) Int J Cardiol , vol.172 , pp. 115-121
    • Triposkiadis, F.K.1    Butler, J.2    Karayannis, G.3
  • 38
    • 84890369206 scopus 로고    scopus 로고
    • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial
    • Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial. JAMA 2013; 310: 2533-2543.
    • (2013) JAMA , vol.310 , pp. 2533-2543
    • Chen, H.H.1    Anstrom, K.J.2    Givertz, M.M.3
  • 39
    • 46549093415 scopus 로고
    • Hemodynamic effects of nitroglycerin and longacting nitrates
    • Abrams J. Hemodynamic effects of nitroglycerin and longacting nitrates. Am Heart J 1985; 110: 216-224.
    • (1985) Am Heart J , vol.110 , pp. 216-224
    • Abrams, J.1
  • 40
    • 66249133670 scopus 로고    scopus 로고
    • Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure
    • Den Uil CA, Lagrand WK, Spronk PE, et al. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail 2009; 11: 386-390.
    • (2009) Eur J Heart Fail , vol.11 , pp. 386-390
    • Den Uil, C.A.1    Lagrand, W.K.2    Spronk, P.E.3
  • 41
    • 0032492071 scopus 로고    scopus 로고
    • Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema
    • Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.
    • (1998) Lancet , vol.351 , pp. 389-393
    • Cotter, G.1    Metzkor, E.2    Kaluski, E.3
  • 42
    • 0029780286 scopus 로고    scopus 로고
    • Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase
    • Munzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J Clin Invest 1996; 98: 1465-1470.
    • (1996) A new action for an old drug. J Clin Invest , vol.98 , pp. 1465-1470
    • Munzel, T.1    Kurz, S.2    Rajagopalan, S.3
  • 43
    • 0025770138 scopus 로고
    • A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
    • Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
    • (1991) N Engl J Med , vol.325 , pp. 303-310
    • Cohn, J.N.1    Johnson, G.2    Ziesche, S.3
  • 45
    • 79952193097 scopus 로고    scopus 로고
    • Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure
    • Chow SL, O'Barr SA, Peng J, et al. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. J Cardiac Fail 2011; 17: 181-187.
    • (2011) J Cardiac Fail , vol.17 , pp. 181-187
    • Chow, S.L.1    O'Barr, S.A.2    Peng, J.3
  • 46
    • 0037027487 scopus 로고    scopus 로고
    • Nitrate tolerance: A unifying hypothesis
    • Gori T and Parker JD. Nitrate tolerance: A unifying hypothesis. Circulation 2002; 106: 2510-2513.
    • (2002) Circulation , vol.106 , pp. 2510-2513
    • Gori, T.1    Parker, J.D.2
  • 47
    • 46249114127 scopus 로고    scopus 로고
    • Sodium nitroprusside for advanced low-output heart failure
    • Mullens W, Abrahams Z, Francis GS, et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 2008; 52: 200-207.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 200-207
    • Mullens, W.1    Abrahams, Z.2    Francis, G.S.3
  • 48
    • 0026044161 scopus 로고
    • Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children
    • Linakis JG, Lacouture PG and Woolf A. Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children. Pediatr Cardiol 1991; 12: 214-218.
    • (1991) Pediatr Cardiol , vol.12 , pp. 214-218
    • Linakis, J.G.1    Lacouture, P.G.2    Woolf, A.3
  • 49
    • 0020026722 scopus 로고
    • Effect of shortterm infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure
    • Cohn JN, Franciosa JA, Francis GS, et al. Effect of shortterm infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. N Engl J Med 1982; 306: 1129-1135.
    • (1982) N Engl J Med , vol.306 , pp. 1129-1135
    • Cohn, J.N.1    Franciosa, J.A.2    Francis, G.S.3
  • 50
    • 0034721244 scopus 로고    scopus 로고
    • Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
    • Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000; 343: 246-253.
    • (2000) Nesiritide Study Group. N Engl J Med , vol.343 , pp. 246-253
    • Colucci, W.S.1    Elkayam, U.2    Horton, D.P.3
  • 51
    • 0037181511 scopus 로고    scopus 로고
    • Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial
    • VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002; 287: 1531-1540.
    • (2002) JAMA , vol.287 , pp. 1531-1540
    • VMAC Investigators1
  • 52
    • 79960090547 scopus 로고    scopus 로고
    • Effect of nesiritide in patients with acute decompensated heart failure
    • O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
    • (2011) N Engl J Med , vol.365 , pp. 32-43
    • O'Connor, C.M.1    Starling, R.C.2    Hernandez, A.F.3
  • 53
    • 77954623284 scopus 로고    scopus 로고
    • Relaxin: Review of biology and potential role in treating heart failure
    • Teichman S, Unemori E, Teerlink J, et al. Relaxin: Review of biology and potential role in treating heart failure. Curr Heart Fail Rep 2010; 7: 75-82.
    • (2010) Curr Heart Fail Rep , vol.7 , pp. 75-82
    • Teichman, S.1    Unemori, E.2    Teerlink, J.3
  • 54
    • 84871986523 scopus 로고    scopus 로고
    • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial
    • Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial. Lancet 2013; 381: 29-39.
    • (2013) Lancet , vol.381 , pp. 29-39
    • Teerlink, J.R.1    Cotter, G.2    Davison, B.A.3
  • 55
    • 4043174201 scopus 로고    scopus 로고
    • The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure
    • Cotter G, Kaluski E, Stangl K, et al. The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure. Eur J Heart Fail 2004; 6: 601-609.
    • (2004) Eur J Heart Fail , vol.6 , pp. 601-609
    • Cotter, G.1    Kaluski, E.2    Stangl, K.3
  • 56
    • 35848944656 scopus 로고    scopus 로고
    • Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
    • McMurray JJ, Teerlink JR, Cotter G, et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA 2007; 298: 2009-2019.
    • (2007) JAMA , vol.298 , pp. 2009-2019
    • McMurray, J.J.1    Teerlink, J.R.2    Cotter, G.3
  • 58
    • 27644562291 scopus 로고    scopus 로고
    • Vasopressin antagonism in heart failure
    • Goldsmith SR and Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 2005; 46: 1785-1791.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1785-1791
    • Goldsmith, S.R.1    Gheorghiade, M.2
  • 59
    • 11144355788 scopus 로고    scopus 로고
    • Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial
    • Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial. JAMA 2004; 291: 1963-1971.
    • (2004) JAMA , vol.291 , pp. 1963-1971
    • Gheorghiade, M.1    Gattis, W.A.2    O'Connor, C.M.3
  • 60
    • 52949114492 scopus 로고    scopus 로고
    • Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: A doseranging pilot study
    • Goldsmith SR, Elkayam U, Haught WH, et al. Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: A doseranging pilot study. J Cardiac Fail 2008; 14: 641-647.
    • (2008) J Cardiac Fail , vol.14 , pp. 641-647
    • Goldsmith, S.R.1    Elkayam, U.2    Haught, W.H.3
  • 61
    • 34848887450 scopus 로고    scopus 로고
    • The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment
    • Dittrich HC, Gupta DK, Hack TC, et al. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Cardiac Fail 2007; 13: 609-617.
    • (2007) J Cardiac Fail , vol.13 , pp. 609-617
    • Dittrich, H.C.1    Gupta, D.K.2    Hack, T.C.3
  • 62
    • 0037133628 scopus 로고    scopus 로고
    • BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy
    • Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348-1353.
    • (2002) Circulation , vol.105 , pp. 1348-1353
    • Gottlieb, S.S.1    Brater, D.C.2    Thomas, I.3
  • 63
    • 44249100426 scopus 로고    scopus 로고
    • Renal effects of ularitide in patients with decompensated heart failure
    • Lüss H, Mitrovic V, Seferovic PM, et al. Renal effects of ularitide in patients with decompensated heart failure. Am Heart J 2008, 155: 1012.e1-8.
    • (2008) Am Heart J , vol.155 , pp. 1012e1-1018e1
    • Lüss, H.1    Mitrovic, V.2    Seferovic, P.M.3
  • 64
    • 84872002780 scopus 로고    scopus 로고
    • Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
    • Erdmann E, Semigran MJ, Nieminen MS, et al. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J 2013; 34: 57-67.
    • (2013) Eur Heart J , vol.34 , pp. 57-67
    • Erdmann, E.1    Semigran, M.J.2    Nieminen, M.S.3
  • 65
    • 77955982186 scopus 로고    scopus 로고
    • CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease
    • McKie PM, Sangaralingham SJ and Burnett JC Jr. CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease. Curr Heart Fail Rep 2010; 7: 93-99.
    • (2010) Curr Heart Fail Rep , vol.7 , pp. 93-99
    • McKie, P.M.1    Sangaralingham, S.J.2    Burnett, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.